FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,516,237 | +55.6% | 715,149 | +249.3% | 0.00% | – |
| Q2 2023 | $974,536 | -51.1% | 204,726 | -41.4% | 0.00% | -100.0% |
| Q1 2023 | $1,991,506 | +35692.7% | 349,529 | -36.6% | 0.00% | -50.0% |
| Q4 2022 | $5,564 | -99.9% | 551,469 | +130.1% | 0.00% | 0.0% |
| Q3 2022 | $5,371,000 | -18.9% | 239,682 | -10.3% | 0.00% | 0.0% |
| Q2 2022 | $6,620,000 | -56.1% | 267,166 | -31.3% | 0.00% | -60.0% |
| Q1 2022 | $15,088,000 | -37.8% | 389,116 | -6.1% | 0.01% | -28.6% |
| Q4 2021 | $24,254,000 | +28.2% | 414,477 | +29.9% | 0.01% | +16.7% |
| Q3 2021 | $18,912,000 | +70.1% | 319,069 | +149.1% | 0.01% | +50.0% |
| Q2 2021 | $11,117,000 | +107.5% | 128,065 | +97.7% | 0.00% | +100.0% |
| Q1 2021 | $5,357,000 | +82.1% | 64,762 | +100.1% | 0.00% | +100.0% |
| Q4 2020 | $2,942,000 | +276.7% | 32,358 | +42.1% | 0.00% | – |
| Q2 2020 | $781,000 | +54.3% | 22,771 | 0.0% | 0.00% | – |
| Q1 2020 | $506,000 | +7.7% | 22,771 | -5.1% | 0.00% | – |
| Q4 2019 | $470,000 | +76.7% | 24,000 | +2.1% | 0.00% | – |
| Q2 2018 | $266,000 | +16.2% | 23,500 | 0.0% | 0.00% | – |
| Q1 2018 | $229,000 | +59.0% | 23,500 | 0.0% | 0.00% | – |
| Q4 2017 | $144,000 | +54.8% | 23,500 | 0.0% | 0.00% | – |
| Q3 2017 | $93,000 | +22.4% | 23,500 | 0.0% | 0.00% | – |
| Q2 2017 | $76,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |